These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36624361)

  • 1. Examining Endpoint Concordance in Clinical Trials and Real-World Clinical Practice to Advance Real-World Evidence Utilization.
    Schaumberg D; Larholt K; Apgar E; Pashos CL; Hirsch G
    Ther Innov Regul Sci; 2023 May; 57(3):472-475. PubMed ID: 36624361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using Bayesian Evidence Synthesis Methods to Incorporate Real-World Evidence in Surrogate Endpoint Evaluation.
    Wheaton L; Papanikos A; Thomas A; Bujkiewicz S
    Med Decis Making; 2023 Jul; 43(5):539-552. PubMed ID: 36998240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia.
    Webster J; Smith BD
    Clin Ther; 2019 Feb; 41(2):336-349. PubMed ID: 30709609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bridging the Gap Between RCTs and RWE Through Endpoint Selection.
    LoCasale RJ; Pashos CL; Gutierrez B; Dreyer NA; Collins T; Calleja A; Seewald MJ; Plumb JM; Liwing J; Tepie MF; Khosla S
    Ther Innov Regul Sci; 2021 Jan; 55(1):90-96. PubMed ID: 32632753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies: First Results From the RCT DUPLICATE Initiative.
    Franklin JM; Patorno E; Desai RJ; Glynn RJ; Martin D; Quinto K; Pawar A; Bessette LG; Lee H; Garry EM; Gautam N; Schneeweiss S
    Circulation; 2021 Mar; 143(10):1002-1013. PubMed ID: 33327727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of real-world evidence for oncology clinical decision making in emerging economies.
    Petracci F; Ghai C; Pangilinan A; Suarez LA; Uehara R; Ghosn M
    Future Oncol; 2021 Aug; 17(22):2951-2960. PubMed ID: 34044583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of real-world evidence in regulatory decisions for rare diseases in the United States-Current status and future directions.
    Wu J; Wang C; Toh S; Pisa FE; Bauer L
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1213-1218. PubMed ID: 32003065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication of randomized clinical trial results using real-world data: paving the way for effectiveness decisions.
    Sheffield KM; Dreyer NA; Murray JF; Faries DE; Klopchin MN
    J Comp Eff Res; 2020 Oct; 9(15):1043-1050. PubMed ID: 32914653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What types of real-world evidence studies do U.S. commercial health plans cite in their specialty drug coverage decisions?
    Panzer AD; Margaretos NM; Lai RC; Enright DE; Chambers JD
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1307-1311. PubMed ID: 32212282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing-Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative.
    Orsini LS; Berger M; Crown W; Daniel G; Eichler HG; Goettsch W; Graff J; Guerino J; Jonsson P; Lederer NM; Monz B; Mullins CD; Schneeweiss S; Brunt DV; Wang SV; Willke RJ
    Value Health; 2020 Sep; 23(9):1128-1136. PubMed ID: 32940229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translational hurdles with cannabis medicines.
    Graham M; Lucas CJ; Schneider J; Martin JH; Hall W
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1325-1330. PubMed ID: 32281186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Expanding Role of Real-World Evidence Trials in Health Care Decision Making.
    Klonoff DC
    J Diabetes Sci Technol; 2020 Jan; 14(1):174-179. PubMed ID: 30841738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Use of Real-World Evidence and Data in Clinical Research and Postapproval Safety Studies.
    Lamberti MJ; Kubick W; Awatin J; McCormick J; Carroll J; Getz K
    Ther Innov Regul Sci; 2018 Nov; 52(6):778-783. PubMed ID: 29714579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trial designs using real-world data: The changing landscape of the regulatory approval process.
    Baumfeld Andre E; Reynolds R; Caubel P; Azoulay L; Dreyer NA
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1201-1212. PubMed ID: 31823482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real world evidence (RWE) - a disruptive innovation or the quiet evolution of medical evidence generation?
    Khosla S; White R; Medina J; Ouwens M; Emmas C; Koder T; Male G; Leonard S
    F1000Res; 2018; 7():111. PubMed ID: 30026923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Real-World Evidence to Drive Drug Development Strategy and Inform Clinical Trial Design.
    Dagenais S; Russo L; Madsen A; Webster J; Becnel L
    Clin Pharmacol Ther; 2022 Jan; 111(1):77-89. PubMed ID: 34839524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration.
    Chan K; Nam S; Evans B; de Oliveira C; Chambers A; Gavura S; Hoch J; Mercer RE; Dai WF; Beca J; Tadrous M; Isaranuwatchai W
    BMJ Open; 2020 Jan; 10(1):e032884. PubMed ID: 31915169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conducting Real-world Evidence Studies on the Clinical Outcomes of Diabetes Treatments.
    Schneeweiss S; Patorno E
    Endocr Rev; 2021 Sep; 42(5):658-690. PubMed ID: 33710268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.